Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-11-2016 | Letter to the Editor

Strategy based on kinetics of O-(2-[¹⁸F] fluoroethyl)-L-tyrosine ([¹⁸F] FET)

Authors: Masashi Kameyama, Yumi Umeda-Kameyama

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 12/2016

Excerpt

Dear Sir, …

Albert NL, Winkelmann I, Suchorska B, Wenter V, Schmid-Tannwald C, Mille E, et al. Early static ¹⁸F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans. Eur J Nucl Med Mol Imaging. 2016;43:1105–1114. doi:10.1007/s00259-015-3276-2.CrossRefPubMed

Pöpperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ, et al. Analysis of ¹⁸F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?. J Nucl Med. 2006;47:393–403.PubMed

Galldiks N, Stoffels G, Filss CP, Piroth MD, Sabel M, Ruge MI, et al. Role of O-(2-¹⁸F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med. 2012;53:1367–1374. doi:10.2967/jnumed.112.103325.CrossRefPubMed

Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[¹⁸F] fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205–212.PubMed

Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res Rev. 1982;4:237–274. doi:10.1016/0165-0173(82)90018-2.CrossRef

Sokoloff L, Reivich M, Kennedy C, Des Rosiers M, Patlak C, Pettigrew K, et al. The [¹⁴C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977; 28: 897–916. doi:10.1111/j.1471-4159.1977.tb10649.x.CrossRefPubMed

Valentina G, Silvia M, Marco P. Dual-phase amyloid PET: hitting two birds with one stone. Eur J Nucl Med Mol Imaging. 2016;43:1300–1303. doi:10.1007/s00259-016-3393-6.CrossRefPubMed

Okubo S, Zhen HN, Kawai N, Nishiyama Y, Haba R, Tamiya T. Correlation of L-methyl- ¹¹C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas. J Neurooncol. 2010; 99: 217–225. doi:10.1007/s11060-010-0117-9.CrossRefPubMed

Takenaka S, Asano Y, Shinoda J, Nomura Y, Yonezawa S, Miwa K, et al. Comparison of ¹¹C-methionine, ¹¹C-choline, and ¹⁸F-fluorodeoxyglucose-positron emission tomography for distinguishing glioma recurrence from radiation necrosis. Neurol Med Chir (Tokyo). 2014;54: 280–289. doi:10.2176/nmc.oa2013-0117.CrossRef

10.

Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, et al. Diagnostic accuracy of ¹¹C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med. 2008;49: 694–699.CrossRefPubMed

11.

Stöber B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl- ³H] methionine (MET) and O-(2-[¹⁸F] fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging. 2006; 33:932–939.CrossRefPubMed

Title: Strategy based on kinetics of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET)
Authors: Masashi Kameyama
Yumi Umeda-Kameyama
Publication date: 01-11-2016
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-016-3470-x

At a glance: The STEP trials

Springer Medicine

Strategy based on kinetics of O-(2-[¹⁸F] fluoroethyl)-L-tyrosine ([¹⁸F] FET)

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2016

Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer

Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism

Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease

TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib

In memoriam: Prof. Ignac Fogelman (04.09.1948 – 05.07.2016)